Events Calendar
Events in detail
2007
EFORT (European Federation of National Associations of Orthopaedics and Traumatology)
EFORT (11 - 15 May 2007)
8th EFORT Congress
Florence, Italy
The European Federation of Orthopaedics and Traumatology (EFORT) promotes the exchange of scientific knowledge and experience. As a Pan-European organisation, EFORT is recognised as representing an outstanding level of orthopaedics.
Xarelto® Programme
| Date | Event | Relevant material | Location | Time |
|---|---|---|---|---|
|
May 13th |
Advances in the surgical and clinical management of orthopaedic patients The future potential of oral anticoagulation with rivaroxaban — a once-daily, direct Factor Xa inhibitor. Michael Rud Lassen |
Michelangelo Room, Fortezza da Basso |
12.15–13.45 |
|
|
May 13th |
Guidelines for thromboprophylaxis after major orthopaedic surgery William Geerts |
|
12.15 |
|
|
May 13th |
Minimally invasive hip replacement: the MicroHipTM technique Markus Michel |
|
12.35 |
|
|
May 13th |
Evolution of minimally invasive surgery in total joint arthroplasty: learning curves and pitfalls Louis Kwong |
|
12.50 |
|
|
May 13th |
Anticoagulants for use after major orthopaedic surgery: the story so far … Ander T Cohen |
|
13.05 |
|
|
May 13th |
Anticoagulation with rivaroxaban — a novel, oral, direct Factor Xa inhibitor Bengt Eriksson |
|
13.20 |
|
|
May 13th |
Summary Michael Rud Lassen |
|
13.40 |
|
|
May 13th |
Close
|
|
13.45 |
|
|
May 13th |
The effect of age, gender and weight on the safety and pharmacology of rivaroxaban (BAY 59-7939) – a novel, oral, direct Factor Xa inhibitor Dagmar Kubitza, Michael Becka, Wolfgang Mueck, Michael Zuehlsdorf |
|
Poster |
|
|
May 13th |
Rivaroxaban – a novel, oral, direct Factor Xa inhibitor – has no clinically relevant interaction with Aspirin or naproxen Dagmar Kubitza, Michael Becka, Wolfgang Mueck, Michael Zuehlsdorf |
|
Poster |
2008
AHA (American Heart Association)
AHA (8-12 November 2008 )
American Heart Association's Scientific Sessions 2008
New Orleans, US
The American Heart Association's Scientific Sessions is the premier cardiovascular meeting that offers scientific programming in three broad areas of clinical, basic and population science as well as cross-disciplinary translational science due to the ever-increasing integration of research and patient care.
Xarelto® Programme
| Date | Event | Relevant material | Location | Time |
|---|---|---|---|---|
|
Nov 10th |
Plenary Session: Randomized Comparison of Rivaroxaban, an Oral Direct Factor Xa Inhibitor, with Placebo in Patients with Acute Coronary Syndromes: The ATLAS ACS-TIMI 46 Trial Michael C. Gibson |
New Orleans - Congress Center, Hall F |
10:45 - 11 am |
ASH (American Society of Hematology)
ASH (6-9 December 2008 )
50th ASH Annual Meeting and Exposition
San Francisco, US
Held annually in December, the Society's annual meeting provides hematologists from around the world a forum for discussing critical issues in hematology.
Xarelto® Programme
| Date | Event | Relevant material | Location | Time |
|---|---|---|---|---|
|
Dec 5th |
CME Symposium - New Perspectives, New Strategies in Venous Thromboembolic Disease Jeffrey Weitz, Charles T. Esmon, Alexander G.G. Turpie and Richard Joel Friedman |
San Francisco Marriott – Yerba Buena Ballroom, Salon 9 |
6 – 10 pm |
|
|
Dec 6th |
Poster Presentation - Rivaroxaban for Prevention of Venous Thromboembolism after Total Knee Replacement: Impact on Healthcare Costs Based on the RECORD4 Study Louis Kwong |
Moscone Center, Hall A, Poster Board No: I-394 |
5:30 – 7:30 pm |
|
|
Dec 6th |
Poster Presentation - Will Rivaroxaban be Cost-effective for Prevention of Venous Thromboembolism after Total Hip Replacement in US Patients? Louis Kwong |
Moscone Center, Hall A, Poster Board No: I-395 |
5:30 – 7:30 pm |
|
|
Dec 6th |
Poster Presentation - Cost-effectiveness of Rivaroxaban as VTE Prophylaxis after Total Hip Replacement in Canada Philip Wells |
Moscone Center, Hall A, Poster Board No: I-396 |
5:30 – 7:30 pm |
|
|
Dec 6th |
Poster - Indirect Comparisons of Rivaroxaban Versus Alternative Prophylaxes for the Prevention of VTE in Patients Undergoing Total Knee Replacement Alexander Diamantopoulos |
Moscone Center, Hall A, Poster Board No: I-397 |
||
|
Dec 7th |
Paper - Once-Daily Oral Rivaroxaban Compared with Subcutaneous Enoxaparin Every 12 Hours for Thromboprophylaxis after Total Knee Replacement: RECORD4 Alexander GG Turpie |
Moscone Center |
5:30 pm |
|
|
Dec 7th |
Paper - A Pooled Analysis of Four Pivotal Studies of Rivaroxaban for the Prevention of Venous Thromboembolism after Orthopaedic Surgery: Effect on Symptomatic Venous Thromboembolism, Death, and Bleeding Alexander GG Turpie |
Moscone Center |
5:45 pm |
|
|
Dec 7th |
Poster Presentation - A Pooled-analysis of Four Pivotal Studies of Rivaroxaban for the Prevention of Venous Thromboembolism after Orthopaedic Surgery: Effects of Specified Co-Medications Bengt Eriksson |
Moscone Center, Hall A,Poster Board No: II-80 |
6 – 8 pm |
|
|
Dec 8th |
Paper - Alignment to ACCP Prophylaxis Guidelines and VTE Outcomes in THR and TKR Patients Bijan Borah |
Moscone Center |
8:15 am |
|
|
Dec 8th |
Paper - Effects of Age, Weight, Gender and Renal Function in a Pooled Analysis of Four Phase III Studies of Rivaroxaban for Prevention of Venous Thromboembolism after Major Orthopedic Surgery Kenneth A. Bauer |
Moscone Center |
2:15 pm |
|
|
Dec 8th |
Paper - Direct Thrombin Inhibitors, but Not Factor Xa Inhibitors, Enhance Thrombin Formation in Human Plasma by Interfering with the Thrombin–Thrombomodulin– Protein C System Elisabeth Perzborn |
Moscone Center |
2:45 pm |
|
|
Dec 8th |
Poster Presentation - Potential of Activated Prothrombin Complex Concentrate and Activated Factor VII to Reverse the Anticoagulant Effects of Rivaroxaban in Primates András Gruber |
Moscone Center, Hall A, Poster Board No: III-907 |
5:30 – 7:30 pm |
|
|
Dec 8th |
Poster - Effects of the Novel, Oral, Direct Factor Xa Inhibitor Rivaroxaban on Coagulation Assays Meyer Michel Samama |
Moscone Center, Hall A, Poster Board No: III-110 |
||
|
Dec 8th |
Poster - Improvement of Thrombolysis by Rivaroxaban, An Anti Xa Inhibitor. Potential Therapeutic Importance in Patients with Thrombosis Remi Varin |
Moscone Center, Hall A, Poster Board No: III-113 |
CHEST (American College of Chest Physicians)
CHEST (25-30 October 2008 )
CHEST 2008
Philadelphia, PA
Recognized around the world as the authority in clinical chest medicine, CHEST 2008 is the one event that can deliver education, experience, expertise.
EFORT (European Federation of National Associations of Orthopaedics and Traumatology)
EFORT (29 May - 1 June 2008)
9th EFORT Congress
Nice, France
The scientific programme includes symposia and instructional lectures delivered by distinguished speakers from across Europe, free papers, posters, workshops, industry symposia and technical exhibits.
Xarelto® Programme
| Date | Event | Relevant material | Location | Time |
|---|---|---|---|---|
|
May 30th |
Improving patient outcomes after major orthopaedic surgery Bengt Eriksson and Alexander GG Turpie |
Nice Acropolis |
12:00 - 14:00 |
|
|
May 30th |
Introduction Bengt Eriksson, Sweden |
|
12:15 |
|
|
May 30th |
What's new in total hip and knee replacement? Wolfgang Klauser, Germany |
|
|
|
|
May 30th |
Total hip and knee replacement: an anaesthetist's perspective Nadja Rosencher, France |
|
|
|
|
May 30th |
Reducing the risk of VTE after total hip replacement Ajay Kakkar, UK |
|
|
|
|
May 30th |
Reducing the risk of symptomatic VTE after total knee replacement Michael Rud Lassen, Denmark |
|
|
|
|
May 30th |
Summary Alexander GG Turpie |
|
|
|
|
May 30th |
Close
|
|
14:00 |
EHA (European Hematology Association)
EHA (12-15 June 2008 )
13th Congress of the European Hematology Association
Copenhagen, Denmark
The Scientific Program Committee of the European Haematology Association and its Advisory Board have taken much effort to generate a timely and stimulating program covering the broad spectrum of benign and malignant hematology.
ESC (European Society of Cardiology)
ESC (30 August - 3 September 2008 )
ESC Congress 2008
Munich, Germany
The ESC congress provides a unique forum where medical professionals from all around the world have the opportunity to meet and exchange ideas and information in the field of cardiovascular medicine. The theme of this year's congress: cardiovascular imaging.
Xarelto® Programme
| Date | Event | Relevant material | Location | Time |
|---|---|---|---|---|
|
Sep 1st |
Anticoagulant therapy: new perspectives in cardiovascular medicine The current role of anticoagulants in cardiovascular medicine The need for new oral anticoagulants in clinical practice What can ongoing clinical trials demonstrate? New anticoagulants in developments clinical perspectives C Bode, FWA Verheugt |
Oslo- Zone A1 |
18:30 - 20:00 |
|
|
Welcome and introduction Christoph Bode, Germany |
18:30–18:40 |
|||
|
The current role of anticoagulants in cardiovascular medicine Raffaele de Caterina, Italy |
18:40–18:55 |
|||
|
The need for new oral anticoagulants in clinical practice Elaine Hylek, USA |
18:55–19:10 |
|||
|
What can ongoing clinical trials demonstrate? Jonathan Halperin, USA |
19:10–19:25 |
|||
|
New anticoagulants in development: clinical perspectives Thomas Lüscher, Switzerland |
19:25–19:40 |
|||
|
Panel and audience discussion |
19:40–19:55 |
|||
|
Close Freek Verheugt, The Netherlands |
19:55–20:00 |
|||
|
02. Sep 08 - Abstract Number: 81940, Poster Session 5 (Number 305), Posters Zone B4 The oral, direct factor Xa inhibitor rivaroxaban prevented right ventricular pressure increase and hypertrophy without increasing bleeding in a pulmonary artery hypertension model in rats Elisabeth Perzborn |
||||
|
03. Sep 08 - Abstract Number: 85236, Poster Session 7 (Number: 307), Posters Zone B4 Hypercoagulability in rats is increased by low doses of the direct thrombin inhibitor melagatran, but is reduced by the direct factor Xa inhibitor rivaroxaban Elisabeth Perzborn |
||||
|
03. Sep 08 - Abstract Number: 86450, Poster Session 7 (Number 307), Posters Zone B4 A meta-analysis of three pivotal studies of rivaroxaban for thromboprophylaxis after orthopaedic surgery: effect on symptomatic venous thromboembolism, all-cause mortality and bleeding Alexander GG Turpie |
ICT (International Congress on Thrombosis)
ICT (25–28 June 2008)
20th International Congress on Thrombosis
Athens, Greece
International Thrombosis Congress of MLTD (The Meditteranean League against Thromboembolic Diseases) offers exchange of views and updates on technological advances in the management of Thromboembolic Diseases, as well as new drugs and new therapeutic techniques.
Xarelto® Programme
| Date | Event | Relevant material | Location | Time |
|---|---|---|---|---|
|
Jun 27th |
Key Note Lecture Reducing the risk of symptomatic VTE after major orthopaedic surgery: learnings from the RECORD programme Sylvia Haas, Germany |
Room Terpsichore A, Hilton Hotel |
11:00–11:30 |
|
|
Recombinant Factor VIIa reverses the effects of a high dose of rivaroxaban in baboons Andras Gruber, Ulla M Marzec, Ulf Buetehorn, Stephen R Hanson, Elisabeth Perzborn |
Poster |
|||
|
Economic impact of venous thromboprophylaxis with rivaroxaban after major orthopaedic surgery Michael Lees, Nishan Sengupta |
Poster |
|||
|
No interaction between rivaroxaban – a novel, oral, direct Factor Xa inhibitor – and atorvastatin Dagmar Kubitza, Wolfgang Mueck, Michael Becka |
||||
|
Indirect comparison of rivaroxaban regimens vs standard prophylaxis for the prevention of venous thromboembolism in patients undergoing total hip or total knee replacement Alexander Diamantopoulos, Corinne LeReun, Farhat Rasul, Michael Lees, Maria Kubin |
Poster |
|||
|
FEIBA reverses the effects of a high dose of rivaroxaban in rats Elisabeth Perzborn, Hanna Tinel |
Poster |
|||
|
Relationship between urinary prothrombin fragment 1+2 levels and venous thromboembolic or bleeding events following total hip replacement Lars C Borris, Morten Breindahl, Michael Rud Lassen, Akos Ferenc Pap, Frank Misselwitz |
Poster |
|||
|
Effects of rivaroxaban and fondaparinux on clotting assays Meyer Michel Samama, Léna Le Flem, Céline Guinet, Elisabeth Perzborn, Jean-Luc Martinoli, François Depasse |
Poster |
|||
|
Measuring rivaroxaban pharmacodynamics: prothrombinase-induced clotting time (PiCT®) and Heptest® Meyer Michel Samama, Léna Le Flem, Céline Guinet, Elisabeth Perzborn, François Depasse |
Poster |
|||
|
Concomitant administration of rivaroxaban – an oral, direct Factor Xa inhibitor – with clopidogrel and acetylsalicylic acid enhances antithrombosis in rats Elisabeth Perzborn, Elke Fischer, Uwe Lange |
Poster |
|||
|
Economic burden of venous thromboembolism in the general population and after major orthopaedic surgery – results of a systematic literature review Thomas Steinle, Andras Ruppert, Michael Lees |
Poster |
ISPOR (International Society for Pharmacoeconomics and Outcomes Research)
ISPOR (8-11 November 2008)
ISPOR 11th Annual European Congress
Athens, Greece
The International Society for Pharmacoeconomics and Outcomes Research is an international organization promoting the science of pharmacoeconomics and health outcomes research. ISPOR is organized to act as a scientific leader relevant to research in pharmacoeconomics, health outcomes assessment, and related issues of public policy.
Xarelto® Programme
| Date | Event | Relevant material | Location | Time |
|---|---|---|---|---|
|
Nov 10th |
Poster - Cost-effectiveness of rivaroxaban versus enoxaparin for thromboprophylaxis after total hip replacement in Spain Diamantopoulos A |
Hilton Athens |
8 am - 7:30 pm |
|
|
Nov 10th |
Poster - Cost-effectiveness of rivaroxaban versus enoxaparin for thromboprophylaxis after total hip replacement in Canada Diamantopoulos A |
Hilton Athens |
8 am - 7:30 pm |
|
|
Nov 10th |
Poster - Cost-effectiveness of rivaroxaban versus enoxaparin for thromboprophylaxis after total knee replacement in the UK and Spain Diamantopoulos A |
Hilton Athens |
8 am - 7:30 pm |
|
|
Nov 10th |
Poster - Cost-effectiveness of rivaroxaban versus enoxaparin for thromboprophylaxis after total hip replacement in the UK Diamantopoulos A |
Hilton Athens |
8 am - 7:30 pm |
|
|
Nov 10th |
Poster - Prophylaxis with rivaroxaban against venous thromboembolism (VTE): a cost-consequence analysis from the Italian Healthcare Service perspective Negrini C |
Hilton Athens |
8 am - 7:30 pm |
SSC (International Society on Thrombosis and Haemostasis - Scientific and Standardisation Committee meeting)
SSC (2-5 July 2008)
The 54th Annual Scientific and Standardization Committee Meeting
Vienna, Austria
The purpose of the ISTH's Reach the World Initiative is to foster and support world-wide growth of the field of thrombosis, hemostasis, and vascular biology, particularly in economically developing areas; and to support the next generation of investigators with state-of-the-art knowledge in diseases and disorders of thrombosis, hemostasis and their underlying vascular biology.
Xarelto® Programme
| Date | Event | Relevant material | Location | Time |
|---|---|---|---|---|
|
Jul 3rd |
Rivaroxaban: potential clinical impact of simplified oral anticoagulant thromboprophylaxis Exciting results are emerging on a novel, oral, direct Factor Xa inhibitor in development, rivaroxaban. Results of extensive phase III clinical trials – the RECORD programme – that have involved over 12,000 patients worldwide demonstrate the benefits of this oral, easy-to-administer anticoagulant for thromboprophylaxis following total knee or hip replacement and the drug’s potential in other indications. Ajay Kakkar, UK and Kenneth A. Bauer, USA |
Klimt 2, Hilton Vienna |
12:00–13:30 |
|
|
Welcome and introduction Ajay Kakkar, UK and Kenneth A. Bauer, USA |
12:00–12:10 |
|||
|
Clinical benefits of rivaroxaban for thromboprophylaxis after total hip replacement Sylvia Haas, Germany |
12:10–12:35 |
|||
|
Clinical benefits of rivaroxaban for thromboprophylaxis after total knee replacement Walter Ageno, Italy |
12:35–13:00 |
|||
|
Simplifying oral anticoagulation: a clinician’s perspective on rivaroxaban Gregory Lip, UK |
13:00–13:15 |
|||
|
Panel and audience discussion |
13:15–13:30 |
|||
|
Close |
13:30 |
2009
AAOS (American Academy of Orthopaedic Surgeons)
AAOS (25-28 February 2009 )
AAOS 2009 Annual Meeting
Las Vegas, Nevada
The technical exhibits at the AAOS 2009 Annual Meeting, February 25-28, Las Vegas, Nevada, offer you the single, best opportunity to compare products, attend demonstrations and have questions answered by representatives from over 400 companies from around the world.
Xarelto® Programme
| Date | Event | Relevant material | Location | Time |
|---|---|---|---|---|
|
Feb 27th |
Thromboprophylaxis with Rivaroxaban versus Enoxaparin after Total Knee Replacement: RECORD4 Alexander G Turpie, Canada |
Venetian Hotel Room 3105 |
12:18 - 12:24 |
ACC (American College of Cardiology - 58th Annual Scientific Session)
ACC (29-31 Mar 2009 )
American College of Cardiology - 58th Annual Scientific Session
Orlando, Florida
The ACC Annual Scientific Session is the largest and foremost cardiovascular meeting, offering attainable, reliable and applicable learning solutions that help CV professionals turn cardiovascular knowledge to practice that saves and improves lives.
Xarelto® Programme
| Date | Event | Relevant material | Location | Time |
|---|---|---|---|---|
|
Apr 27th |
Educational Satellite Symposia - Anticoagulant Therapy in the Cardiology Patient: The known, the Unknown, the Unknowable |
Peabody Orlando |
2:45 pm |
ACCP/Chest (American College of Chest Physicians)
ACCP/Chest (31 Oct - 5 Nov 2009)
CHEST 2009
San Diego, California
The American College of Chest Physicians (ACCP) is the world’s largest clinical cardiopulmonary and critical care medical society with more than 17,000 members in 100 countries. Members include physicians, allied health professionals, and PhDs from the specialties of pulmonology, critical care medicine, thoracic surgery, cardiology, sleep, and other chest-related specialties.
AHA (American Heart Association's Scientific Sessions 2009)
AHA (14-18 November 2009)
AHA 2009
Orlando, Florida
The American Heart Association's Scientific Sessions is the premier cardiovascular meeting that offers scientific programming in three broad areas of clinical, basic and population science as well as cross-disciplinary translational science due to the ever-increasing integration of research and patient care.
Xarelto® Programme
| Date | Event | Relevant material | Location | Time |
|---|---|---|---|---|
|
Nov 15th |
Poster Presentation - The Effect of Rivaroxaban on Biomarkers of Hypercoagulability in Patients with Chronic Heart Failure M Gheorghiade |
Poster Hall A2-A3, Core 5 |
9:30 - 11:00am |
ASH (American Society of Hematology)
ASH (5–8 Dec 2009)
2009 ASH Annual Meeting
New Orleans, USA
Held annually in December, the Society's annual meeting provides hematologists from around the world a forum for discussing critical issues in hematology.
Xarelto® Programme
| Date | Event | Relevant material | Location | Time |
|---|---|---|---|---|
|
Dec 6th |
Poster Presentation - Prothrombin Time and Bleeding Events in Patients Undergoing Total Hip or Knee Replacement Surgery Receiving 10 mg Rivaroxaban S Haas |
Hall E, Poster Board II-76 |
6:00 - 8:00 pm |
|
|
Dec 7th |
Oral Session - Quantitative Benefit–Risk Assessment of Rivaroxaban for the Prevention of Venous Thromboembolism B Levitan |
275-277 |
7:00 am |
|
|
Dec 8th |
Late-Breaking Abstract Session - Once-Daily Oral Rivaroxaban Versus Placebo in the Long-Term Prevention of Recurrent Symptomatic Venous Thromboembolism. the Einstein-Extension Study H Buller |
Hall F |
7:30 - 9:00 am |
EAHP (European Association of Hospital Pharmacists)
EAHP (25-27 Mar 2009)
14th congress of the European Association of Hospital Pharmacists
Barcelona, Spain
Entitled "IT and Automation for the Hospitals Pharmacists - tools for better care", the congress will address topics that are at the forefront of the daily work of hospital pharmacists in the field of computerization and technology, in addition to a variety of other subjects for which the EAHP congress has become recognised as one of the premier educational events worldwide in the spring season of each year.
Xarelto® Programme
| Date | Event | Relevant material | Location | Time |
|---|---|---|---|---|
|
Mar 25th |
Satellite Symposium - Thrombosis management: simplified anticoagulation therapy with oral Factor Xa inhibitors Alexander GG Turpie, Canada Reinhold Kreutz, Germany |
Barcelona, Auditorium of the Palacio de Congressos de Catalunya |
11:30 am - 1 pm |
EFORT (European Federation of National Associations of Orthopaedics and Traumatology)
EFORT (3-6 June 2009 )
10th EFORT Congress
Vienna, Austria
EFORT’s 10th Anniversary Congress in Vienna. The scientific programme includes symposia and instructional lectures delivered by distinguished speakers from across Europe.
Xarelto® Programme
| Date | Event | Relevant material | Location | Time |
|---|---|---|---|---|
|
Jun 3rd |
3rd - 6th June: A Kidd |
E-poster area |
||
|
Jun 4th |
Satellite Symposium - Bayer Schering Pharma - Clot Prevention now a whole lot easier…The role of direct Factor Xa inhibition after elective hip and knee arthroplasty Lars Borris, Denmark |
Austria Center Vienna, Auditorium Room K |
12 - 2 pm |
|
|
Jun 5th |
Oral Presentation - A pooled analysis of four pivotal studies of rivaroxaban for the prevention of venous thromboembolism after hip or knee arthroplasty AGG Turpie |
Austria Center Vienna, Auditorium Room K |
4:40 pm |
|
|
Jun 5th |
Oral Presentation - Economic impact of Rivaroxaban versus Enoxaparin for Prevention of Venous Thromboembolism after Total Hip and Total Knee Arthroplasty in Sweden L Ryttberg |
Austria Center Vienna, Auditorium Room K |
4:50 pm |
|
|
Jun 5th |
Oral Presentation - Pooled analysis of four clinical studies of rivaroxaban after hip and knee arthroplasty: effects of NSAIDs and ASA L Borris |
Austria Center Vienna, Auditorium Room K |
5:00 pm |
EHA (European Hematology Association)
EHA (4-7 June 2009 )
14th Congress of the European Hematology Association
Berlin, Germany
The 14th Congress of the EHA will provide a comprehensive program for clinical and basic hematologists. Important information will be offered in education, scientific, controversial and poster sessions.
ESA (European Society of Anaesthesiology)
ESA (6 – 9 June 2009)
Euroanaesthesia 2009
Italy, Milan
The ESA organises the European Anaesthesiology Congresses throughout Europe under the banner EUROANAESTHESIA. These meetings are attended by members and non-members representing more than 80 countries from around the world. The European Anaesthesiology Congresses offer a comprehensive scientific programme of refresher course lectures, symposia and workshops, together with presentation and discussion of the latest research undertaken in Europe in particular. The European Anaesthesiology Congresses are organised with active participation of the National Societies, and joint meetings are held with them on occasion. The European Anaesthesiology Congresses are accredited by the U.E.M.S./EACCME for C.M.E. credits. More than 100 exhibitors participate in the industrial exhibition at the EUROANAESTHESIA annual meeting.
Xarelto® Programme
| Date | Event | Relevant material | Location | Time |
|---|---|---|---|---|
|
Jun 8th |
Industrial Symposium Bayer Schering Pharma AG - Thrombosis management…today and beyond: Practical aspects in the management of patients undergoing elective hip or knee replacement surgery Nadja Rosencher, France |
Yellow 1 & 2, Level 1, Milano Convention Centre, Milan, Italy |
12:30 - 1:30 pm |
ESC (European Society of Cardiology)
ESC (29 Aug – 1Sep 2009)
ESC Congress 2009
Barcelona, Spain
The ESC Congress, the largest medical meeting in Europe, is an international meeting and one of the leading events in cardiology.
Xarelto® Programme
| Date | Event | Relevant material | Location | Time |
|---|---|---|---|---|
|
Aug 31st |
Satellite Symposium: Thrombosis management in cardiology: the relevance of direct Factor Xa inhibition J-P Bassand, KAA Fox |
Sofia - Zone 1 |
6:30-8:00 pm |
|
|
Aug 31st |
Poster Presentation - Concomitant administration of low-dose rivaroxaban – an oral, direct Factor Xa inhibitor – with clopidogrel and acetylsalicylic acid enhances antithrombotic efficacy in rats E Perzborn |
Posters - Zone 3 |
8:30am-12:30pm |
|
|
Sep 1st |
Poster Presentation - Rationale and design of the ROCKET AF study: Rivaroxaban Once daily, oral, direct Factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Tr M Patel |
Posters - Zone 3 |
8:30am-12:30pm |
ESRA (European Society of Regional Anaesthesia & Pain Therapy)
ESRA (9-12 Sept 2009)
XXVIII Annual ESRA Congress
Salzburg, Austria
The XXVIII Annual ESRA Congress, to be held in the beautiful Austrian town of Salzburg, will attract over 1,500 anaesthesiologists, physicians and scientists who use regional anaesthesia for surgery, obstetrics and paediatrics and pain control.
ICNC (International Conference of Non-Invasive Cardiovascular Imaging (ESC))
ICNC (10-13 May 2009 )
International Conference of Non-Invasive Cardiovascular Imaging
Barcelona, Spain
The goal of ICNC9, a joint endeavour between the American Society of Nuclear Cardiology (ASNC), the European Association of Nuclear Medicine (EANM) and the ESC Working Group on Nuclear Cardiology and Cardiac Computed Tomography (ESC), is the emphasis on education and continued growth of cardiac imaging within nuclear cardiology.
ISTH (International Society on Thrombosis and Haemostasis)
ISTH (11-16 Jul 2009 )
55th Meeting of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis
Boston, US
The International Society on Thrombosis and Haemostasis, Inc. is organized and operated exclusively for scientific and educational purposes. Its objectives are to foster and advance science relating to the important medical problems of thrombosis and abnormalities of hemostasis and vascular biology; to provide a forum for discussion of these problems; to encourage research on these problems by scientists of the relevant disciplines; to foster the diffusion and exchange of ideas through scientific meetings and publications; to standardize nomenclature and methods as appropriate and timely.
Xarelto® Programme
| Date | Event | Relevant material | Location | Time |
|---|---|---|---|---|
|
Jul 13th |
Poster Presentation - Suitability of a Well-Established Chromogenic Anti-Factor Xa Assay for Measuring the Pharmacodynamics of Rivaroxaban A Karst |
Poster Area, Hall B2 |
12:30 - 2:15 pm |
|
|
Jul 13th |
Poster Presentation - Prothrombin Complex Concentrate Reverses the Effects of High-Dose Rivaroxaban in Rats E Perzborn |
Poster Area, Hall B2 |
12:30 - 2:15 pm |
|
|
Jul 13th |
Poster Presentation - Inhibition of Thrombin Generation in Human Plasma by Rivaroxaban, an Oral, Direct Factor Xa Inhibitor E Perzborn |
Poster Area, Hall B2 |
12:30 - 2:15 pm |
|
|
Jul 13th |
Poster Presentation - Assessment of Factor Xa Chromogenic Assays for Measuring the Pharmacodynamics of Rivaroxaban – an Oral, Direct Factor Xa Inhibitor E Perzborn |
Poster Area, Hall B2 |
12:30 - 2:15 pm |
|
|
Jul 13th |
Poster Presentation - Economic Comparison of Rivaroxaban with Enoxaparin in Canadian Patients Undergoing Total Hip and Total Knee Replacement P Wells |
Poster Area, Hall B2 |
12:30 - 2:15 pm |
|
|
Jul 15th |
Poster Presentation - Effects of Age, Weight, Gender, and Renal Function in a Pooled Analysis of Four Rivaroxaban Studies K Bauer |
Poster Area, Hall B2 |
12:30 - 2:15 pm |
|
|
Jul 15th |
Poster Presentation - Pooled Analysis of Four Rivaroxaban Studies: NSAIDs, ASA and Platelet Inhibitors B Eriksson |
Poster Area, Hall B2 |
12:30 - 2:15 pm |
|
|
Jul 15th |
Poster Presentation - Suitability of Chromogenic Anti-Factor Xa Methods to Measure Rivaroxaban in Human Plasma M Samama |
Poster Area, Hall B2 |
12:30 - 2:15 pm |
|
|
Jul 15th |
Poster Presentation - Effects of Rivaroxaban, a Novel, Oral, Direct Factor Xa Inhibitor, on Coagulation Assays M Samama |
Poster Area, Hall B2 |
12:30 - 2:15 pm |
|
|
Jul 15th |
Poster Presentation - Cost-Effectiveness of Rivaroxaban for Prevention of Deep Vein Thrombosis and Pulmonary Embolism after Total Hip or Knee Replacement in US Patients L Kwong |
Poster Area, Hall B2 |
12:30 - 2:15 pm |
|
|
Jul 15th |
Poster Presentation - Impact of Venous Thromboembolism on US Medicare Patients Undergoing Total Hip and Total Knee Replacement Surgery O Baser |
Poster Area, Hall B2 |
12:30 - 2:15 pm |
|
|
Jul 15th |
Poster Presentation - Economic Comparison of Rivaroxaban with Enoxaparin in the UK and Sweden L Ryttberg |
Poster Area, Hall B2 |
12:30 - 2:15 pm |
|
|
Jul 16th |
Poster Presentation - Potential Impact of Rivaroxaban on Surgical Safety Outcomes after Total Hip or Knee Replacement Surgery M Lassen |
Poster Area, Hall B2 |
12:30 - 2:15 pm |
IUA/MLAVS (XIX Meeting of the Mediterranean League of Angiology and Vascular Surgery)
IUA/MLAVS (19-22 Sept 2009)
XIX MLAVS 2009
Palermo, Italy
The Congress is aiming to present and debate the most recent experiences and researches in the field of vascular pathology between angiologists, cardiologists, diabetologists, specialists in internal medicine and geriatrics, haematologists, radiologists, vascular surgeons as well as young post-graduating doctors in these disciplines and nurses.
SICOT (International Society of Orthopaedic Surgery and Traumatology)
SICOT (29 Oct – 01 Nov 2009 )
Sixth SICOT/SIROT Annual International Conference
Pattaya, Thailand
A major topic, among many others at the Conference, will be the treatment of degenerative conditions affecting the musculoskeletal system. The longer human life span has made this subject an imperative for the orthopaedic surgeon.
2010
AAOS (American Academy of Orthopaedic Surgeons)
AAOS (10-13 March 2010)
AAOS 2010 Annual Meeting
Venetian/Sands, New Orleans, USA
Founded in 1933, the Academy is the preeminent provider of musculoskeletal education to orthopaedic surgeons and others in the world. Its continuing medical education activities include a world-renowned Annual Meeting, multiple CME courses held around the country and at the Orthopaedic Learning Center, and various medical and scientific publications and electronic media materials.
Xarelto® Programme
| Date | Event | Relevant material | Location | Time |
|---|---|---|---|---|
|
Mar 9th |
Poster Presentation - Oral Rivaroxaban Significantly Reduces Symptomatic VTE and Death after THA and TKA Richard Friedman |
Morial Convention Center |
12 – 1 pm |
|
|
Mar 9th |
Poster Presentation - Pooled Analysis of Rivaroxaban after Total Hip and Knee Replacement: Effects of Co-medications Bengt I Eriksson |
Morial Convention Center |
12 – 1 pm |
|
|
Mar 9th |
Poster Presentation - A Pooled Analysis of Surgical Complications: Results from the RECORD Program Michael R Lassen |
Morial Convention Center |
12 – 1 pm |
|
|
Mar 9th |
Poster Presentation - Pooled Data from Rivaroxaban Clinical Trials: Timing of Symptomatic VTE and Bleeding Events after THA William D Fisher |
Morial Convention Center |
12 – 1 pm |
|
|
Mar 10th |
Oral Presentation - Pooled Rivaroxaban Clinical Trial Data: Timing of Symptomatic VTE and Bleeding Events after TKA William D Fisher |
Room 243-245 |
1:42 – 1:48 pm |
ACC (American College of Cardiology)
ACC (14–16 March 2010)
American College of Cardiology - 59th Annual Scientific Session
Atlanta, USA
The ACC Annual Scientific Session is the largest and foremost cardiovascular meeting, offering attainable, reliable and applicable learning solutions that help CV professionals turn cardiovascular knowledge to practice that saves and improves lives.
AHA (American Heart Association)
AHA (14-16 Nov 2010)
Scientific Sessions 2010
Chicago, USA
The American Heart Association's Scientific Sessions is the premier cardiovascular meeting that offers scientific programming in three broad areas of clinical, basic and population science as well as cross-disciplinary translational science due to the ever-increasing integration of research and patient care.
ASH (American Society of Hematology)
ASH (4 - 6 Dec 2010)
52nd ASH Annual Meeting and Exposition
Orlando, USA
Held annually in December, the Society's annual meeting provides hematologists from around the world a forum for discussing critical issues in hematology.
CHEST (American College of Chest Physicians)
CHEST (30 Oct - 4 Nov 2010)
CHEST 2010
Vancouver, Canada
The American College of Chest Physicians (ACCP) is the world’s largest clinical cardiopulmonary and critical care medical society with more than 17,000 members in 100 countries. Members include physicians, allied health professionals, and PhDs from the specialties of pulmonology, critical care medicine, thoracic surgery, cardiology, sleep, and other chest-related specialties.
EAHP (European Association of Hospital Pharmacists)
EAHP (24-26 Mar 2010)
15th Congress of the European Association of Hospital Pharmacists
The Nice Acropolis congress centre, Nice, France
European Association of Hospital Pharmacists is a working community of national associations of hospital pharmacists. Its membership includes representatives of national hospital pharmacy associations in almost all the European Union (EU) member states, in addition to Switzerland, Norway, Serbia, Turkey, Croatia and the Former Yugoslav Republic Of Macedonia (FYROM) . Membership is increasing each year and, at present, EAHP represents the interest of over 21,000 hospital pharmacists in 29 countries all over Europe.
Xarelto® Programme
| Date | Event | Relevant material | Location | Time |
|---|---|---|---|---|
|
Mar 25th |
Satellite Symposium: Thrombosis Management...innovation in practice - Rivaroxaban preparing to set new standards P Mismetti |
Salle Hermès |
8:30 - 10 am |
ECAS (European Cardiac Arrhytmia Society)
ECAS (10 Apr - 12 Apr 2011)
About ECAS
Paris, France
ECAS was founded in 2004 by a group of opinion leaders belonging to 11 European Countries who recognized that the educational, research and logistic needs in the field of cardiac arrhythmia are not appropriately fulfilled in Europe. There was an essential need in Europe to have an independent society, composed of physicians, scientists and allied professionals throughout Europe and other countries throughout the World whose mission and goals are devoted to the field of cardiac arrhythmias.
EFORT (European Federation of National Associations of Orthopaedics and Traumatology)
EFORT (2-5 Jun 2010)
11th EFORT Congress 2010
Feria de Madrid - IFEMA, Madrid, Spain
The European Federation of Orthopaedics and Traumatology (EFORT) promotes the exchange of scientific knowledge and experience. As a Pan-European organisation, EFORT is recognised as representing an outstanding level of orthopaedics.
Xarelto® Programme
| Date | Event | Relevant material | Location | Time |
|---|---|---|---|---|
|
Jun 2nd |
Oral Presentation - Timing of symptomatic venous thromboembolism and bleeding events after total knee arthroplasty: A pooled analysis of rivaroxaban studies William D Fisher |
Auditorium N115-116 |
10 - 11:30 am |
|
|
Jun 2nd |
Oral Presentation - Timing of symptomatic venous thromboembolism and bleeding events after total hip arthroplasty: A pooled analysis of rivaroxaban studies William D Fisher |
Auditorium Hall 9, Room 2 |
5 - 6:30 pm |
|
|
Jun 4th |
Satellite Symposium: Cementing the Benefits - Oral anticoagulants in orthopaedic practice WD Fisher and JV Llau |
Room N104 |
1:15 - 2:30 pm |
EHA (European Hematology Association)
EHA (10-13 June 2010)
15th Congress of the EHA
Barcelona, Spain
The Scientific Program Committee of the European Haematology Association and its Advisory Board have taken much effort to generate a timely and stimulating program covering the broad spectrum of benign and malignant hematology.
Xarelto® Programme
| Date | Event | Relevant material | Location | Time |
|---|---|---|---|---|
|
Jun 11th |
Poster Presentation - THE MAGELLAN STUDY METHODOLOGY: RIVAROXABAN COMPARED WITH ENOXAPARIN FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM IN HOSPITALIZED MEDICALLY ILL PATIENTS Alexander Cohen |
Hall 6; 0165 |
5:45 - 7 pm |
|
|
Jun 12th |
Poster Presentation - Rivaroxaban Calibrator And Control Sets Measuring Rivaroxaban Plasma Concentrations Using The Prothrombin Time M Samama |
Hall 6; 0688 |
5:30 - 6:45 pm |
ESA (Europian Society of Aneasthesiology)
ESA (10-15 Jun 2010)
Euroanaesthesia 2010
Helsinki Exibition & Convention center, Helsinki, Finland
The ESA organises the European Anaesthesiology Congresses throughout Europe under the banner EUROANAESTHESIA. These meetings are attended by members and non-members representing more than 80 countries from around the world. The European Anaesthesiology Congresses offer a comprehensive scientific programme of refresher course lectures, symposia and workshops, together with presentation and discussion of the latest research undertaken in Europe in particular. The European Anaesthesiology Congresses are organised with active participation of the National Societies, and joint meetings are held with them on occasion. The European Anaesthesiology Congresses are accredited by the U.E.M.S./EACCME for C.M.E. credits. More than 100 exhibitors participate in the industrial exhibition at the EUROANAESTHESIA annual meeting.
ESC (European Society of Cardiology)
ESC (28 Aug – 1 Sep 2010)
ESC Congress 2010
Stockholm, Sweden
The ESC congress provides a unique forum where medical professionals from all around the world have the opportunity to meet and exchange ideas and information in the field of cardiovascular medicine. The theme of this year's congress: cardiovascular imaging.
Xarelto® Programme
| Date | Event | Relevant material | Location | Time |
|---|---|---|---|---|
|
Aug 30th |
Satellite Symposium - Improving Outcomes in Patients at Risk of Thromboembolic Diseases…Working toward a clot-free future Gregory Lip and Harry Büller |
Zone A, Room Athens |
6:30 - 8 pm |
|
|
Aug 31st |
Poster Presentation - Pharmacokinetics and pharmacodynamics of rivaroxaban in patients with heart failure Mihai Gheorghiade |
Poster Zone |
2 - 6 pm |
|
|
Sep 1st |
Oral - Effects of rivaroxaban, ASA and clopidogrel alone and in combination in a porcine model of stent thrombosis Eva Maria Becker |
Room Tel Aviv |
8:30 - 8:45 am |
|
|
Sep 1st |
Oral - Effects of rivaroxaban on thrombin generation is modified by a P2Y12 receptor blocker Elisabeth Perzborn |
Room Tel Aviv |
8:45 - 9:00 am |
ESC Stroke (European Stroke Conference)
ESC Stroke (25-28 May 2010)
19th European Stroke Conference
Palau de Congressos de Catalunya, Barcelona, Spain
The European Stroke Conference was founded in 1990 by M.G. Hennerici (Germany) and J. Bogousslavsky (Switzerland). The first meeting was held in Düsseldorf and was attended by about 500 people – and proved to be a great success. At that time only the North American conference existed for clinical researchers and basic scientists to present data from stroke research. The prospect to establish another European stroke meeting was highly challenging. After biannual meetings, 1992 in Lausanne and 1994 in Stockholm and increasing attendance, however, the ESC became an annual, international, well-received and continuously growing stroke conference.
HRS (Heart Rhythm Society)
HRS (4 May - 7 May 2011)
About HRS
San Francisco, USA
The Heart Rhythm Society is the international leader in science, education and advocacy for cardiac arrhythmia professionals and patients, and the primary information resource on heart rhythm disorders. Its mission is to improve the care of patients by promoting research, education and optimal health care policies and standards.
ISC (International Stroke Conference)
ISC (13-16 Oct 2010)
International Stroke Conference 2010
San Antonio, USA
The International Stroke Conference features more than 800 presentations highlighting the most recent advances in the basic sciences of cerebral circulation and brain function, clinical stroke research and outcomes, rehabilitation science, and surgery, as well as exhibitors showcasing the newest advancements in stroke products and services.
ISTH (International Society on Thrombosis and Heamostasis)
ISTH (23 Jul - 28 Jul)
About ISTH
Kyoto, Japan
The International Society on Thrombosis and Haemostasis, Inc. is organized and operated exclusively for scientific and educational purposes. Its objectives are to foster and advance science relating to the important medical problems of thrombosis and abnormalities of hemostasis and vascular biology; to provide a forum for discussion of these problems; to encourage research on these problems by scientists of the relevant disciplines; to foster the diffusion and exchange of ideas through scientific meetings and publications; to standardize nomenclature and methods as appropriate and timely.
ESRA (European Society of Regional Anaesthesia & Pain Therapy)
ESRA (8-11 September 2010)
XXIX ESRA Annual Congress
Porto, Portugal
ESRA was founded in 1980 and has since become the leading European association involved in improving and standardizing the level of Regional Anaesthesia in Europe. ESRA’s membership numbers over 2000 and is comprised of the leading anaesthesia specialists in Europe from countries spanning east and west.
ICT (International Congress on Thrombosis)
ICT (6-9 July 2010)
21st International Congress on Thrombosis 2010
Marriott Hotel, Milan, Italy
International Thrombosis Congress of MLTD (The Meditteranean League against Thromboembolic Diseases) offers exchange of views and updates on technological advances in the management of Thromboembolic Diseases, as well as new drugs and new therapeutic techniques.
Xarelto® Programme
| Date | Event | Relevant material | Location | Time |
|---|---|---|---|---|
|
Jul 8th |
Poster presentation - DIFFERENT CHARACTERISTICS OF DIRECT FACTOR XA INHIBITORS: IN VITRO COMPARATIVE STUDIES OF RIVAROXABAN AND APIXABAN Elisabeth Perzborn |
Hall Manzoni |
12:30 - 2:30 pm |
|
|
Jul 8th |
Oral - PROTHROMBIN COMPLEX CONCENTRATE REVERSES THE EFFECTS OF HIGH-DOSE RIVAROXABAN IN RATS Elisabeth Perzborn |
Hall Washington A |
9:30-11 am |
|
|
Jul 8th |
Poster presentation - Rivaroxaban Calibrator And Control Sets Measuring Rivaroxaban Plasma Concentrations Using The Prothrombin Time MM Samama |
Hall Manzoni |
12:30 - 2:30 pm |
ICTHIC (International Conference on Thrombosis and Hemostasis Issues in Cancer )
ICTHIC (23-25 Apr 2010)
Fifth Conference 2010
Palazzo dei Congressi of Stresa, Stresa, Italy
The association between cancer and thrombosis has been known for more than a century and, since its original description, this association has had several definitions, including: 1. The increased risk of venous thromboembolism (VTE) as a complication of Cancer (as first described by Armand Trousseau in 1865); 2. The increased risk of an occult cancer in patients with idiopathic VTE (also described by Trousseau); 3. the likelihood that tumors possessed characteristics that activate blood coagulation (again, an observation of Trousseau); and, finally, 4. The possibility of a relation between the clotting mechanisms and the enhancement of tumor growth and the development of metastases (as postulated by Billroth in 1878).
ISPOR (International Society for Pharmacoeconomics and Outcomes Research)
ISPOR (15-19 May 2010)
ISPOR 15th Annual International Meeting
Hilton Atlanta, Atlanta, USA
ISPOR promotes the science of pharmacoeconomics (health economics) and outcomes research (the scientific discipline that evaluates the effect of health care interventions on patient well-being including clinical outcomes, economic outcomes, and patient-reported outcomes) and facilitates the translation of this research into useful information for healthcare decision-makers to ensure that society allocates scarce health care resources wisely, fairly and efficiently.
IUA/MLAVS (International Union of Angiology/Mediterranean League of Angiology and Vascular Surgery)
IUA/MLAVS (21-25 April 2010)
2010 XXIV World Congress of the International Union of Angiology
Sheraton Buenos Aires Hotel & Convention Center, Buenos Aires, Argentina
The Congress is aiming to present and debate the most recent experiences and researches in the field of vascular pathology between angiologists, cardiologists, diabetologists, specialists in internal medicine and geriatrics, haematologists, radiologists, vascular surgeons as well as young post-graduating doctors in these disciplines and nurses.
SICOT/SIROT (Int. Society of Orthopaedic Surgery and Traumatology/Int. Research Society of Orthopaecic Surgery and Traumatology)
SICOT/SIROT (31 Aug - 3 Sep 2010)
Seventh SICOT/SIROT Annual International Conference combined meeting with the Swedish Orthopaedic Association
Gothenburg, Sweden
SICOT is an international non-profit association incorporated under Belgian law with the aim to advance the science and art of orthopaedics and traumatology at an international level and to foster and develop teaching, research and education.
SIROT is an international society, an offshoot of SICOT, and was founded in 1978. SIROT's purpose is to promote orthopaedic research and an understanding of its clinical relevance throughout the world.
SSC (International Society on Thrombosis and Haemostasis - Scientific and Standardisation Committee meeting)
SSC (22-25 May 2010)
56th Annual Scientific and Standardization Committee Meeting
Grand Hyatt Hotel, Cairo, Egypt
The purpose of the ISTH's Reach the World Initiative is to foster and support world-wide growth of the field of thrombosis, hemostasis, and vascular biology, particularly in economically developing areas; and to support the next generation of investigators with state-of-the-art knowledge in diseases and disorders of thrombosis, hemostasis and their underlying vascular biology.
Xarelto® Programme
| Date | Event | Relevant material | Location | Time |
|---|---|---|---|---|
|
May 23rd |
Key Note Lecture: M Prins |
The Auditorium, Fifth Floor |
1 - 1:45 pm |
WSC (World Stroke Congress)
WSC (13-16 Oct 2010)
7th World Stroke Congress
Seoul, Korea
The 7th World Stroke Congress, organized by the World Stroke Organization (WSO), is a landmark event attended biennially by top medical doctors and professionals interested in finding global strategies to combat the second most common cause of death worldwide.
The WSO Seoul 2010 Congress will facilitate the dissemination and discussion of all aspects of stroke and provide a platform for experts to present groundbreaking information. It is also a superb opportunity to network, and to strengthen scientific collaboration to improve the care of stroke victims throughout the world.
2011
AAOS (American Academy of Orthopedic Surgeons)
AAOS (15 Feb - 19 Feb 2011)
American Academy of Orthopedic Surgeons
San Diego, USA
About AAOS: Founded in 1933, the Academy is the preeminent provider of musculoskeletal education to orthopaedic surgeons and others in the world. Its continuing medical education activities include a world-renowned Annual Meeting, multiple CME courses held around the country and at the Orthopaedic Learning Center, and various medical and scientific publications and electronic media materials.
ACC (American College of Cardiology)
ACC (2 Apr - 5 Apr 2011)
American College of Cardiology
New Orleans, USA
About ACC: The American College of Cardiology is leading the way to optimal cardiovascular care and disease prevention. The College is a 39,000 member nonprofit medical professional society and bestows the credential Fellow of the American College of Cardiology upon physicians who meet its stringent qualifications. The College is a leader in the formulation of health policy, standards and guidelines, and is a staunch supporter of cardiovascular research. The ACC provides professional education and operates national registries for the measurement and improvement of quality care.
AHA (American Heart Association)
AHA (12 Nov - 16 Nov 2011)
American Heart Association
Orlando, USA
About AHA: The American Heart Association's Scientific Sessions is the premier cardiovascular meeting that offers scientific programming in three broad areas of clinical, basic and population science as well as cross-disciplinary translational science due to the ever-increasing integration of research and patient care.
ASH (American Society of Hematology)
ASH (10 Dec - 13 Dec 2011)
American Society of Hematology
San Diego, USA
About ASH: The American Society of Hematology (ASH) is the world’s largest professional society concerned with the causes and treatments of blood disorders. The mission of the Society is to further the understanding, diagnosis, treatment, and prevention of disorders affecting the blood, bone marrow, and the immunologic, hemostatic and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology.
CHEST (American College of Chest Physicians)
CHEST (22 Oct - 27 Oct 2011)
American College of Chest Physicians
Honolulu, USA
About CHEST: The American College of Chest Physicians (ACCP) is the world’s largest clinical cardiopulmonary and critical care medical society with more than 17,000 members in 100 countries. Members include physicians, allied health professionals, and PhDs? from the specialties of pulmonology, critical care medicine, thoracic surgery, cardiology, sleep, and other chest-related specialties.
EAHP (European Association of Hospital Pharmacists)
EAHP (30 Mar - 1 Apr 2011)
European Association of Hospital Pharmacists
Vienna, Austria
About EAHP: European Association of Hospital Pharmacists is a working community of national associations of hospital pharmacists. Its membership includes representatives of national hospital pharmacy associations in almost all the European Union (EU) member states, in addition to Switzerland, Norway, Serbia, Turkey, Croatia, the Former Yugoslav Republic Of Macedonia (FYROM) and Bosnia Herzegovina.
ECAS (European Cardiac Arrhytmia Society)
ECAS (10 Apr - 12 Apr 2011)
European Cardiac Arrhytmia Society
Paris, France
About ECAS: ECAS was founded in 2004 by a group of opinion leaders belonging to 11 European Countries who recognized that the educational, research and logistic needs in the field of cardiac arrhythmia are not appropriately fulfilled in Europe. There was an essential need in Europe to have an independent society, composed of physicians, scientists and allied professionals throughout Europe and other countries throughout the World whose mission and goals are devoted to the field of cardiac arrhythmias.
EFORT (European Federation of National Associations of Orthopaedics and Traumatology)
EFORT (1 Jun - 4 Jun 2011)
European Federation of National Associations of Orthopaedics and Traumatology
Copenhagen, Denmark
About EFORT: EFORT is the umbrella organisation linking Europe‘s national orthopaedic associations. Its aims reflect the will of all the participating associations to promote the exchange of scientific knowledge and experience in the field of prevention and both the conservative and surgical treatment of diseases and injuries concerning the musculo-skeletal system.
EHA (European Hematology Association)
EHA (9 Jun - 12 Jun 2011)
European Hematology Association
London, United Kingdom
About EHA: The European Hematology Association was founded in June 1992. Today, EHA – with over 3000 active members from 95 countries – is a consolidated organization that pursues a large and growing number of projects and programs.
ESA (European Society of Anaesthesiology)
ESA (11 Jun - 14 Jun 2011)
European Society of Anaesthesiology
Amsterdam, The Netherlands
About ESA: The European Society of Anaesthesiology (ESA) resulted from the amalgamation of the former European Society of Anaesthesiologists (ESA), the European Academy of Anaesthesiology (EAA) and the Confederation of European National Societies of Anaesthesiologists (CENSA) and holds the most prominent position in the community of anaesthesiologists in Europe and elsewhere.
ESC (European Society of Cardiology)
ESC (27 Aug - 31 Aug 2011)
European Society of Cardiology
Paris, France
About ESC: The European Society of Cardiology (ESC) represents 59,000 cardiology professionals across Europe and the Mediterranean. It provides an array of scientific and educational activities, such as the production and continuous updating of Clinical Practice Guidelines, the organisation of educational courses and initiatives, pan-European surveys on specific disease areas.
ESC Stroke (European Stroke Conference)
ESC Stroke (24 - 27 May 2011)
ESC Stroke
Hamburg, Germany
About ESC Stroke: The European Stroke Conference was founded in 1990 by M.G. Hennerici (Germany) and J. Bogousslavsky (Switzerland).
HRS (Heart Rhythm Society)
HRS (4 May - 7 May 2011)
Heart Rhythm Society
San Francisco, USA
About HRS: The Heart Rhythm Society is the international leader in science, education and advocacy for cardiac arrhythmia professionals and patients, and the primary information resource on heart rhythm disorders. Its mission is to improve the care of patients by promoting research, education and optimal health care policies and standards.
ISC (International Stroke Conference)
ISC (9 Feb - 11 Feb 2011)
International Stroke Conference
Los Angeles, USA
About ISC: The International Stroke Conference features more than 800 presentations highlighting the most recent advances in the basic sciences of cerebral circulation and brain function, clinical stroke research and outcomes, rehabilitation science, and surgery, as well as exhibitors showcasing the newest advancements in stroke products and services.
ISTH (International Society on Thrombosis and Heamostasis)
ISTH (23 Jul - 28 Jul)
International Society on Thrombosis and Heamostasis
Kyoto, Japan
About ISTH: The International Society on Thrombosis and Haemostasis, Inc. is organized and operated exclusively for scientific and educational purposes. Its objectives are to foster and advance science relating to the important medical problems of thrombosis and abnormalities of hemostasis and vascular biology; to provide a forum for discussion of these problems; to encourage research on these problems by scientists of the relevant disciplines; to foster the diffusion and exchange of ideas through scientific meetings and publications; to standardize nomenclature and methods as appropriate and timely.
2012
ACC (American College of Cardiology)
ACC (24 Mar – 27 Mar 2012)
American College of Cardiology
Chicago, USA
The American College of Cardiology is leading the way to optimal cardiovascular care and disease prevention. The College is a 39,000 member nonprofit medical professional society and bestows the credential Fellow of the American College of Cardiology upon physicians who meet its stringent qualifications. The College is a leader in the formulation of health policy, standards and guidelines, and is a staunch supporter of cardiovascular research. The ACC provides professional education and operates national registries for the measurement and improvement of quality care.
AHA (American Heart Association)
AHA (4 Nov – 7 Nov 2012)
American Heart Association
Los Angeles, USA
The American Heart Association's Scientific Sessions is the premier cardiovascular meeting that offers scientific programming in three broad areas of clinical, basic and population science as well as cross-disciplinary translational science due to the ever-increasing integration of research and patient care.
ASH (American Society of Hematology)
ASH (7 Dec – 11 Dec 2012)
American Society of Hematology
Atlanta, USA
The American Society of Hematology (ASH) is the world’s largest professional society concerned with the causes and treatments of blood disorders. The mission of the Society is to further the understanding, diagnosis, treatment, and prevention of disorders affecting the blood, bone marrow, and the immunologic, hemostatic and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology.
CHEST (American College of Chest Physicians)
CHEST (20 Oct – 25 Oct 2012)
American College of Chest Physicians
Atlanta, USA
About CHEST: The American College of Chest Physicians (ACCP) is the world’s largest clinical cardiopulmonary and critical care medical society with more than 17,000 members in 100 countries. Members include physicians, allied health professionals, and PhDs? from the specialties of pulmonology, critical care medicine, thoracic surgery, cardiology, sleep, and other chest-related specialties.
EAHP (European Association of Hospital Pharmacists)
EAHP (21 Mar – 23 Mar 2012)
European Association of Hospital Pharmacists
Milan, Italy
European Association of Hospital Pharmacists is a working community of national associations of hospital pharmacists. Its membership includes representatives of national hospital pharmacy associations in almost all the European Union (EU) member states, in addition to Switzerland, Norway, Serbia, Turkey, Croatia, the Former Yugoslav Republic Of Macedonia (FYROM) and Bosnia Herzegovina.
EFORT (European Federation of National Associations of Orthopaedics and Traumatology)
EFORT (23 May – 25 May 2012)
European Federation of National Associations of Orthopaedics and Traumatology
Berlin, Germany
EFORT is the umbrella organisation linking Europe‘s national orthopaedic associations. Its aims reflect the will of all the participating associations to promote the exchange of scientific knowledge and experience in the field of prevention and both the conservative and surgical treatment of diseases and injuries concerning the musculo-skeletal system.
EHA (European Hematology Association)
EHA (14 Jun – 17 Jun 2012)
European Hematology Association
Amsterdam, The Netherlands
The EHA congresses showcase the latest research, relevant both to basic and clinical scientists as well as state of the art Education Sessions for clinicians and hematologists in training. The program will include Molecular Hemopoiesis and Laboratory Hematology Workshops, Hematology-in-Focus and Meet-the-Expert sessions, as well as Lunch Debates and the EHA Scientific Working Groups. A number of joint symposia will also be organized to cover diverse topics related to the field of hematology.
ESC (European Society of Cardiology)
ESC (25 Aug – 29 Aug 2012)
European Society of Cardiology
Munich, Germany
The European Society of Cardiology (ESC) represents 59,000 cardiology professionals across Europe and the Mediterranean. It provides an array of scientific and educational activities, such as the production and continuous updating of Clinical Practice Guidelines, the organisation of educational courses and initiatives, pan-European surveys on specific disease areas.
Eurostroke (European Stroke Conference)
Eurostroke (22 May – 25 May 2012)
European Stroke Conference
Lisbon, Portugal
The European Stroke Conference was founded in 1990 by M.G. Hennerici (Germany) and J. Bogousslavsky (Switzerland).
ICT (International Thrombosis Congress of MLTD)
ICT (6 Oct – 9 Oct 2012)
International Thrombosis Congress of MLTD
Nice, France
The International Thrombosis Congress of MLTD (The Mediterranean League against Thromboembolic Diseases) offers exchange of views and updates on technological advances in the management of Thromboembolic Diseases, as well as new drugs and new therapeutic techniques.
ISC (International Stroke Conference)
ISC (1 Feb – 3 Feb 2012)
International Stroke Conference
New Orleans, USA
The International Stroke Conference features more than 800 presentations highlighting the most recent advances in the basic sciences of cerebral circulation and brain function, clinical stroke research and outcomes, rehabilitation science, and surgery, as well as exhibitors showcasing the newest advancements in stroke products and services.
SSC (Scientific & Standardization Committee of the ISTH)
SSC (27 Jun - 30 Jun 2012)
Scientific & Standardization Committee of the ISTH
Liverpool, UK
ISTH is an international individual membership organization with over 3,000 members around the world. Its mission remains the advancement of education and stimulation of research into thrombosis and hemostasis through meetings, peer-reviewed publications and expert committees on practical issues related to research methods and standards. The ISTH with the Committee, now the Scientific and Standardization Committee of ISTH, provide expert consultation to national and international regulatory agencies and health organizations.
WCC (World Congress of Cardiology)
WCC (18 Apr – 21 Apr 2012)
World Congress of Cardiology
Dubai, United Arab Emirates
The World Heart Federation is the world's only global body dedicated to leading the fight against heart disease and stroke. We do this via a united community of almost 200 member organizations that bring together the strength of medical societies and heart foundations, from more than 100 countries.
2013
ISC (International Stroke Conference)
ISC (6 Feb – 8 Feb 2013)
International Stroke Conference
Honolulu, USA
The International Stroke Conference features more than 800 presentations highlighting the most recent advances in the basic sciences of cerebral circulation and brain function, clinical stroke research and outcomes, rehabilitation science, and surgery, as well as exhibitors showcasing the newest advancements in stroke products and services.
ACC (American College of Cardiology)
ACC (March 9 - 11, 2013)
American College of Cardiology
San Francisco, USA
The American College of Cardiology is leading the way to optimal cardiovascular care and disease prevention. The College is a 39,000 member nonprofit medical professional society and bestows the credential Fellow of the American College of Cardiology upon physicians who meet its stringent qualifications. The College is a leader in the formulation of health policy, standards and guidelines, and is a staunch supporter of cardiovascular research. The ACC provides professional education and operates national registries for the measurement and improvement of quality care.
EAHP (European Association of Hospital Pharmacists)
EAHP (March 13 - 15, 2013)
European Association of Hospital Pharmacists
Paris, France
European Association of Hospital Pharmacists is a working community of national associations of hospital pharmacists. Its membership includes representatives of national hospital pharmacy associations in almost all the European Union (EU) member states, in addition to Switzerland, Norway, Serbia, Turkey, Croatia, the Former Yugoslav Republic Of Macedonia (FYROM) and Bosnia Herzegovina.
AAOS (American Academy of Orthopaedic Surgeons)
AAOS (March 19 - 23, 2013)
American Academy of Orthopaedic Surgeons
Chicago, USA
Founded in 1933, the Academy is the preeminent provider of musculoskeletal education to orthopaedic surgeons and others in the world. Its continuing medical education activities include a world-renowned Annual Meeting, multiple CME courses held around the country and at the Orthopaedic Learning Center, and various medical and scientific publications and electronic media materials.
EuroPCR (European Association for Percutaneous Cardiovascular Interventions)
EuroPCR (May 21 - 24, 2013)
European Association for Percutaneous Cardiovascular Interventions
Paris, France
The mission of PCR is to serve the needs of each individual patient by helping the cardiovascular community share knowledge, experience and practice. EuroPCR is the official annual meeting of the European Association for Percutaneous Cardiovascular Interventions.
Eurostroke (European Stroke Conference)
Eurostroke (May 28 - 31, 2013)
European Stroke Conference
London, UK
The European Stroke Conference was founded in 1990 by M.G. Hennerici (Germany) and J. Bogousslavsky (Switzerland). The first meeting was held in Düsseldorf and was attended by about 500 people – and proved to be a great success. At that time only the North American conference existed for clinical researchers and basic scientists to present data from stroke research. The prospect to establish another European stroke meeting was highly challenging. After biannual meetings, 1992 in Lausanne and 1994 in Stockholm and increasing attendance, however, the ESC became an annual, international, well-received and continuously growing stroke conference.
EFORT (European Federation of National Associations of Orthopaedics and Traumatology)
EFORT (June 5 - 8, 2013)
European Federation of National Associations of Orthopaedics and Traumatology
Istanbul, Turkey
EFORT is the umbrella organisation linking Europe‘s national orthopaedic associations. Its aims reflect the will of all the participating associations to promote the exchange of scientific knowledge and experience in the field of prevention and both the conservative and surgical treatment of diseases and injuries concerning the musculo-skeletal system. To this end, particular emphasis is placed upon activities focusing on education and research.
EHRA Europace (European Heart Rhythm Association)
EHRA Europace (23 Jun 2013 - 26 Jun 2013)
European Heart Rhythm Association
Athens – Greece
The legacy of the largest European electrophysiological community – European Heart Rhythm Association (EHRA) - comes from a recent, yet greatly successful past and continues in a shared dynamic vision: to reduce the mortality and morbidity of patients with cardiac arrhythmias and to improve their quality of life.
ISTH (International Society of Thrombosis and Haemostasis)
ISTH (June 29 - July 4, Berlin)
International Society of Thrombosis and Haemostasis
Amsterdam, The Netherlands
The International Society on Thrombosis and Haemostasis, Inc. is organized and operated exclusively for scientific and educational purposes. Its objectives are to foster and advance science relating to the important medical problems of thrombosis and abnormalities of hemostasis and vascular biology; to provide a forum for discussion of these problems; to encourage research on these problems by scientists of the relevant disciplines; to foster the diffusion and exchange of ideas through scientific meetings and publications; to standardize nomenclature and methods as appropriate and timely.
ESC (European Society of Cardiology)
ESC (August 31 - September 4, 2013)
European Society of Cardiology
Amsterdam, The Netherlands
The European Society of Cardiology (ESC) represents 75,000 cardiology professionals across Europe and the Mediterranean. It provides an array of scientific and educational activities, such as the production and continuous updating of Clinical Practice Guidelines, the organisation of educational courses and initiatives, pan-European surveys on specific disease areas.
ERS (European Respiratory Society)
ERS (7 – 11 September 2013)
European Respiratory Society
Barcelona, Spain
ERS is the leading professional organisation in its field in Europe. It is broad-based, with some 10,000 members and counting in over 100 countries. Its scope covers both basic science and clinical medicine. ERS seeks to alleviate suffering from respiratory disease and promote lung health through research, sharing of knowledge and through medical and public education.
AHA (American Heart Association)
AHA (November 16 - 20, 2013)
American Heart Association
Dallas, USA
The American Heart Association's Scientific Sessions is the premier cardiovascular meeting that offers scientific programming in three broad areas of clinical, basic and population science as well as cross-disciplinary translational science due to the ever-increasing integration of research and patient care.
ASH (Americal Society of Hematology)
ASH (Decembr 5 - 10, 2013)
Americal Society of Hematology
New Orleans, USA
The American Society of Hematology (ASH) is the world’s largest professional society concerned with the causes and treatments of blood disorders. The mission of the Society is to further the understanding, diagnosis, treatment, and prevention of disorders affecting the blood, bone marrow, and the immunologic, hemostatic and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology.







